HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to find best Pre-Surgery hormone treatment for men with breast cancer
Disease control Recruiting nowThis study tests different hormone therapies in men with breast cancer before they have surgery. The goal is to see which treatment works best to shrink the tumor. About 60 men with hormone receptor-positive breast cancer will take part.
Matched conditions: HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Jose Pablo Leone • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called NKT3964 in adults with advanced or metastatic solid tumors that have not responded to standard treatments. The drug works by degrading a protein (CDK2) that helps cancer cells grow. The study has two parts: first, find…
Matched conditions: HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Stress-Busting program tested for triple negative breast cancer
Symptom relief Recruiting nowThis study tests whether a 10-week stress reduction program is doable and helpful for people with triple negative breast cancer. The program includes relaxation, coping skills, and social support, and also addresses basic needs like utilities or transportation. Researchers will m…
Matched conditions: HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Biomarker-Guided breast cancer trial aims to personalize therapy
Knowledge-focused Recruiting nowThis study is for people with metastatic breast cancer, including estrogen receptor-positive and triple-negative types. It uses biomarkers from tumors and blood to guide treatment choices, comparing how long the cancer stays controlled on the new therapy versus the previous one. …
Matched conditions: HORMONE RECEPTOR-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC